Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big pharma has been looking to artificial intelligence as another tool to help ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new ‌drug candidates to send into human ...

Rapid Adoption of Molecular Modelling, Biocontent Management, and Sequence Analysis Technologies Reshaping How the Pharmaceutical Industry Discovers Next-Generation Therapeutics.Austin, United States, ...

In a new study published in Nature Communications titled, “COOKIE-Pro: Covalent Inhibitor Binding Kinetics 2 Profiling on the Proteome Scale,” researchers at Baylor College of Medicine have developed ...

Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence ...

Healthcare is in the midst of a data-driven revolution. With the convergence of big data, machine learning and AI, the sector is becoming smarter, faster and more predictive. These technologies are ...

AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast datasets for precise, cost-effective solutions. Growth is driven by ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...

New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...

Using artificial intelligence to create new drugs may be the technology’s most important and marketable use. The idea isn’t merely hypothetical anymore, either. It’s now commercialized, even if still ...